XML 29 R17.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
STOCK-BASED COMPENSATION

11. STOCK-BASED COMPENSATION

The following table summarizes the Company’s stock awards granted for each of the periods indicated:

 

 

 

For the Three Months Ended September 30,

 

 

For the Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

Stock options

 

 

97,240

 

 

$

73.88

 

 

 

152,248

 

 

$

51.64

 

 

 

1,256,064

 

 

$

59.08

 

 

 

1,297,747

 

 

$

72.50

 

Restricted stock units

 

 

49,430

 

 

$

148.63

 

 

 

78,073

 

 

$

99.52

 

 

 

592,867

 

 

$

119.36

 

 

 

483,703

 

 

$

132.45

 

 

Stock-based Compensation Expense

For the three months ended September 30, 2020 and 2019, total stock-based compensation expense was $26.9 million and $20.6 million, respectively. For the nine months ended September 30, 2020 and 2019, total stock-based compensation expense was $78.5 million and $56.5 million, respectively. The following table summarizes stock-based compensation expense by function included within the unaudited condensed consolidated statements of operations and comprehensive loss: 

 

 

 

For the Three Months Ended

September 30,

 

 

For the Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

(in thousands)

 

Research and development

 

$

10,645

 

 

$

6,972

 

 

$

31,034

 

 

$

18,982

 

Selling, general and administrative

 

 

16,258

 

 

 

13,665

 

 

 

47,509

 

 

 

37,556

 

Total stock-based compensation expense

 

$

26,903

 

 

$

20,637

 

 

$

78,543

 

 

$

56,538

 

 

The following table summarizes stock-based compensation expense by grant type included within the unaudited condensed consolidated statements of operations and comprehensive loss:

 

 

 

For the Three Months Ended

September 30,

 

 

For the Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

 

(in thousands)

 

Stock options

 

$

16,474

 

 

$

13,941

 

 

$

49,677

 

 

$

39,175

 

Restricted stock awards/units

 

 

8,950

 

 

 

5,233

 

 

 

24,047

 

 

 

14,333

 

Employee stock purchase plan

 

 

1,479

 

 

 

1,463

 

 

 

4,819

 

 

 

3,030

 

Total stock-based compensation expense

 

$

26,903

 

 

$

20,637

 

 

$

78,543

 

 

$

56,538